<scp>IL1RAP</scp> expression and the enrichment of <scp>IL</scp> ‐33 activation signatures in severe neutrophilic asthma-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

IL1RAP expression and the enrichment of IL ‐33 activation signatures in severe neutrophilic asthma

Published:2022-08-28 Issue:1 Volume:78 Page:156-167
ISSN:0105-4538
Container-title:Allergy
language:en
Short-container-title:Allergy

Author:

Badi Yusef Eamon¹²³,Salcman Barbora⁴,Taylor Adam⁵,Rana Batika⁶,Kermani Nazanin Zounemat²,Riley John H.⁴,Worsley Sally⁷,Mumby Sharon¹,Dahlen Sven‐Eric⁸,Cousins David⁹,Bulfone‐Paus Silvia⁴^ORCID,Affleck Karen¹⁰,Chung Kian Fan¹^ORCID,Bates Stewart⁴,Adcock Ian M.¹^ORCID

Affiliation:

1. National Heart and Lung Institute, Imperial College London London UK

2. Data Science Institute, Imperial College London London UK

3. BenevolentAI London UK

4. School of Biological Sciences, University of Manchester Manchester UK

5. GSK Respiratory Therapeutic Area Unit Stevenage UK

6. Orchard Therapeutics London UK

7. GSK Value Evidence and Outcomes, GSK House Brentford UK

8. Institute of Environmental Medicine, Karolinska Institute Stockholm Sweden

9. Department of Respiratory Sciences University of Leicester Leicester UK

10. GSK Adaptive Immunity Research Unit Stevenage UK

Funder

Biotechnology and Biological Sciences Research Council

Medical Research Council

Asthma UK

Imperial College London

Wellcome Trust

Engineering and Physical Sciences Research Council

Innovative Medicines Initiative

Publisher

Wiley

Subject

Immunology,Immunology and Allergy

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/all.15487

Reference53 articles.

1. T-helper Type 2–driven Inflammation Defines Major Subphenotypes of Asthma

2. Type 2 inflammation in asthma — present in most, absent in many

3. IL-33 is a chemoattractant for human Th2 cells

4. The IL-1-Like Cytokine IL-33 Is Constitutively Expressed in the Nucleus of Endothelial Cells and Epithelial Cells In Vivo: A Novel ‘Alarmin’?

Cited by 16 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. From mesenchymal stem cells to their extracellular vesicles: Progress and prospects for asthma therapy;Asian Journal of Pharmaceutical Sciences;2024-08

2. Role and regulators of N6-methyladenosine (m6A) RNA methylation in inflammatory subtypes of asthma: a comprehensive review;Frontiers in Pharmacology;2024-07-23

3. Inhibition of phosphoinositide 3-kinase activity attenuates neutrophilic airway inflammation and inhibits pyrin domain-containing 3 inflammasome activation in an ovalbumin-lipopolysaccharide-induced asthma murine model;Molecular Biology Reports;2024-05-29

4. Advances in non-type 2 severe asthma: from molecular insights to novel treatment strategies;European Respiratory Journal;2024-05-02

5. New targets for type 2-low asthma;The Korean Journal of Internal Medicine;2024-03-01

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3